Abstract B73: Screen among 1200 FDA-approved drug library reveals mitoxantrone as a TRAIL-sensitizing agent for glioblastoma multiforme
Filiz Senbabaoglu(Koç University), Tugba Bagcı-Önder(Koç University), Nathan A. Lack(Koç University), Ahmet Cingöz(Koç University), Ezgi Kaya-Aksoy(TUM Klinikum), Ceyda Açılan(Koç University), Selena Kazancioglu(Koç University)
Cited by 0
Related Papers
Apoptosis: why and how does it occur in biology?
|Cell Biochemistry and Function|2011|227
Genome-wide CRISPR screen identifies PRC2 and KMT2D-COMPASS as regulators of distinct EMT trajectories that contribute differentially to metastasis
|Nature Cell Biology|2022|130
Synthesis, biological characterization and evaluation of molecular mechanisms of novel copper complexes as anticancer agents
|Biochimica et Biophysica Acta (BBA) - General Subjects|2016|90
DNA repair pathways involved in anaphase bridge formation
|Genes Chromosomes and Cancer|2007|63
May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?
|European Journal of Medicinal Chemistry|2019|45